| Targeting cancer with small molecule kinase inhibitors J Zhang, PL Yang, NS Gray Nature Reviews Cancer 9 (1), 28-39, 2009 | 3315 | 2009 |
| Hydrodynamic injection of viral DNA: a mouse model of acute hepatitis B virus infection PL Yang, A Althage, J Chung, FV Chisari Proceedings of the National Academy of Sciences 99 (21), 13825-13830, 2002 | 554 | 2002 |
| Discovery of insect and human dengue virus host factors OM Sessions, NJ Barrows, JA Souza-Neto, TJ Robinson, CL Hershey, ... Nature 458 (7241), 1047-1050, 2009 | 429 | 2009 |
| Immune effectors required for hepatitis B virus clearance PL Yang, A Althage, J Chung, H Maier, S Wieland, M Isogawa, FV Chisari Proceedings of the National Academy of Sciences 107 (2), 798-802, 2010 | 313 | 2010 |
| The immunological evolution of catalysis PA Patten, NS Gray, PL Yang, CB Marks, GJ Wedemayer, JJ Boniface, ... Science 271 (5252), 1086-1091, 1996 | 297 | 1996 |
| c-Src protein kinase inhibitors block assembly and maturation of dengue virus JJH Chu, PL Yang Proceedings of the National Academy of Sciences 104 (9), 3520-3525, 2007 | 165 | 2007 |
| Small molecule degraders of the hepatitis C virus protease reduce susceptibility to resistance mutations M de Wispelaere, G Du, KA Donovan, T Zhang, NA Eleuteri, JC Yuan, ... Nature Communications 10 (1), 3468, 2019 | 159 | 2019 |
| Peptide inhibitors of dengue-virus entry target a late-stage fusion intermediate AG Schmidt, PL Yang, SC Harrison PLoS Pathog 6 (4), e1000851-e1000851, 2010 | 157 | 2010 |
| Small molecules AZD0530 and dasatinib inhibit Dengue Virus RNA replication via Fyn kinase M de Wispelaere, AJ LaCroix, PL Yang Journal of Virology, 2013 | 136 | 2013 |
| Repurposing of Kinase Inhibitors for Treatment of COVID-19 E Weisberg, A Parent, PL Yang, M Sattler, Q Liu, Q Liu, J Wang, C Meng, ... Pharmaceutical research 37 (9), 1-29, 2020 | 131 | 2020 |
| Expression studies of catalytic antibodies HD Ulrich, PA Patten, PL Yang, FE Romesberg, PG Schultz Proceedings of the National Academy of Sciences 92 (25), 11907-11911, 1995 | 127 | 1995 |
| Small-molecule inhibitors of dengue-virus entry AG Schmidt, K Lee, PL Yang, SC Harrison PLoS Pathog 8 (4), e1002627, 2012 | 113 | 2012 |
| Peptide inhibitors of flavivirus entry derived from the E protein stem AG Schmidt, PL Yang, SC Harrison Journal of virology 84 (24), 12549-12554, 2010 | 105 | 2010 |
| Rapid identification of inhibitors that interfere with poliovirus replication using a cell-based assay YC Hwang, JJH Chu, PL Yang, W Chen, MV Yates Antiviral research 77 (3), 232-236, 2008 | 102 | 2008 |
| Targeting host lipid synthesis and metabolism to inhibit dengue and hepatitis C viruses VA Villareal, MA Rodgers, DA Costello, PL Yang Antiviral Research, 2015 | 95 | 2015 |
| A comparative analysis of the immunological evolution of antibody 28B4 J Yin, EC Mundorff, PL Yang, KU Wendt, D Hanway, RC Stevens, ... Biochemistry 40 (36), 10764-10773, 2001 | 94 | 2001 |
| Anti-HCV drugs in the pipeline PL Yang, M Gao, K Lin, Q Liu, VA Villareal Current opinion in virology 1 (6), 607-616, 2011 | 79 | 2011 |
| Inhibition of Flaviviruses by Targeting a Conserved Pocket on the Viral Envelope Protein M de Wispelaere, W Lian, S Potisopon, PC Li, J Jang, SB Ficarro, ... Cell Chemical Biology, 2018 | 78 | 2018 |
| GNF-2 Inhibits Dengue Virus by Targeting Abl Kinases and the Viral E Protein MJ Clark, C Miduturu, AG Schmidt, X Zhu, JD Pitts, J Wang, S Potisopon, ... Cell chemical biology 23 (4), 443-452, 2016 | 71 | 2016 |
| Mutational analysis of the affinity maturation of antibody 48G7 PL Yang, PG Schultz Journal of molecular biology 294 (5), 1191-1201, 1999 | 71 | 1999 |
Mélissanne de WispelaereEvotec在 evotec.com 的电子邮件经过验证
